Filtros de búsqueda

Lista de obras de Rossella Elisei

2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer

artículo científico publicado en 2012

2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer

scientific article published on 28 August 2019

A Comprehensive Meta-analysis of Case-Control Association Studies to Evaluate Polymorphisms Associated with the Risk of Differentiated Thyroid Carcinoma.

artículo científico publicado en 2016

A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion

scientific article published on 29 July 2020

A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer

artículo científico

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer

artículo científico publicado en 2022

A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma

artículo científico publicado en 2016

A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.

artículo científico publicado en 2009

A new germline RET mutation apparently devoid of transforming activity serendipitously discovered in a patient with atrophic autoimmune thyroiditis and primary ovarian failure.

artículo científico publicado en 2004

A patient with MEN1 and end-stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation

artículo científico publicado en 2017

A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment

artículo científico publicado en 2015

Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal

artículo científico publicado en 2002

Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center

scientific article published on 01 March 2020

Acute exogenous TSH administration stimulates leptin secretion in vivo

artículo científico publicado en 2010

Advances in the follow-up of differentiated or medullary thyroid cancer

artículo científico

All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes.

artículo científico publicado en 2004

Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1.

artículo científico publicado en 2003

Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma.

artículo científico publicado en 2018

Anaplastic thyroid cancer therapy: dream or reality? ⬇️

artículo científico publicado el 1 de diciembre de 2012

Anaplastic thyroid cancer: prevalence, diagnosis and treatment.

artículo científico publicado en 2008

Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies

artículo científico publicado en 2017

Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question.

artículo científico publicado en 2010

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

artículo científico publicado en 2013

Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.

artículo científico publicado en 2014

Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma

artículo científico publicado en 2016

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

artículo científico publicado en 2007

BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer

artículo científico publicado en 2018

BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment

artículo científico publicado en 2017

BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer

artículo científico publicado en 2021

BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma

scientific article published on 29 November 2019

BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas

artículo científico publicado en 2004

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study

artículo científico publicado en 2008

BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer

artículo científico publicado en 2008

Biology and clinical application of the NIS gene.

artículo científico publicado en 2003

Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey

artículo científico publicado en 2020

CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma.

artículo científico publicado en 2010

Ca19.9 positivity and doubling time are prognostic factors of mortality in patients with advanced medullary thyroid cancer with no evidence of structural disease progression according to RECIST

artículo científico publicado en 2020

Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer.

artículo científico publicado en 2013

Cabozantinib in progressive medullary thyroid cancer

artículo científico publicado en 2013

Calcitonin estimation in patients with nodular goiter and its significance for early detection of MTC: european comments to the guidelines of the American Thyroid Association

artículo científico publicado en 2013

Calcitonin receptor expression in medullary thyroid carcinoma

artículo científico publicado en 2017

Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line.

artículo científico publicado en 2012

Changing Trend of Thyroglobulin Antibodies in Patients With Differentiated Thyroid Cancer Treated With Total Thyroidectomy Without 131I Ablation

scientific article published on 01 July 2018

Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma

artículo científico publicado en 2011

Circulating neuron-specific enolase in medullary thyroid cancer

scientific article published on 01 May 1986

Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.

artículo científico publicado en 2016

Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma

scientific article published on 01 December 1989

Clinical case seminar in pediatric thyroid disease.

artículo científico publicado en 2014

Clinical impact of molecular techniques for the presurgical diagnosis of differentiated thyroid cancer diagnosis

artículo científico publicado en 2017

Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma

scientific article published on 11 April 2019

Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience.

artículo científico publicado en 2018

Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer

artículo científico publicado en 2007

Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients

scientific article published on 01 January 2007

Conditional apoptosis induced by oncogenic ras in thyroid cells

artículo científico publicado en 2000

Congenital hypothyroidism due to a new deletion in the sodium/iodide symporter protein

artículo científico publicado en 2003

Consenso europeo para el tratamiento de los pacientes con carcinoma tiroideo diferenciado del epitelio folicular

Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients

scientific article published on 01 September 2001

Correction: Inherited variants in genes somatically mutated in thyroid cancer

artículo científico publicado en 2018

Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.

artículo científico publicado en 2006

Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases.

artículo científico publicado en 2010

Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology Group

artículo científico publicado en 2015

Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer

artículo científico publicado en 2016

Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer

artículo científico publicado en 2002

DELAYED 131-I FIRST TREATMENT AFTER SURGERY HAS NO IMPACT ON THE MEDIAN TERM OUTCOME OF PATIENTS WITH INTERMEDIATE RISK DIFFERENTIATED THYROID CANCER

scientific article published on 26 September 2019

Definition and management of radioactive iodine-refractory differentiated thyroid cancer

artículo científico publicado en 2014

Demonstration of the existence of the alternatively spliced form of thyroid peroxidase in normal thyroid

artículo científico publicado en 1991

Detection of metastases from differentiated thyroid cancer by different imaging techniques (neck ultrasound, computed tomography and [18F]-FDG positron emission tomography) in patients with negative post-therapeutic ¹³¹I whole-body scan and detectab

artículo científico publicado en 2014

Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer

artículo científico publicado en 1992

Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor.

artículo científico publicado en 1993

Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment

artículo científico publicado en 2002

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

artículo científico publicado en 2015

Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas

scientific article published on 05 July 2019

Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutations

artículo científico publicado en 1995

Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer.

scientific article published on 10 September 2016

Effects of radioiodine treatment for differentiated thyroid cancer on testis function

artículo científico publicado en 2014

Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial

artículo científico publicado en 2020

Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer

artículo científico publicado en 2015

Epidemiology of Simultaneous Medullary and Papillary Thyroid Carcinomas (MTC/PTC): An Italian Multicenter Study

artículo científico publicado en 2019

Establishment of a non-tumorigenic papillary thyroid cell line (FB-2) carrying the RET/PTC1 rearrangement

artículo científico publicado en 2002

European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International Symposium.

artículo científico publicado en 2019

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

artículo científico publicado en 2006

Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series.

artículo científico publicado en 2012

Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma

artículo científico publicado en 2011

Exploratory analysis of biomarkers associated with clinical outcomes from the study of lenvatinib in differentiated cancer of the thyroid.

artículo científico publicado en 2017

Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors

artículo científico publicado en 2008

Expression of cAMP response element-binding protein and sodium iodide symporter in benign non-functioning and malignant thyroid tumours

artículo científico publicado en 2003

Expression of calcitonin gene-related peptide in medullary thyroid cancer

artículo científico publicado en 1992

Expression of p21 ras protein as a prognostic factor in papillary thyroid cancer

scientific article published on 01 January 1994

Expression of thyrotropin receptor (TSH-R), thyroglobulin, thyroperoxidase, and calcitonin messenger ribonucleic acids in thyroid carcinomas: evidence of TSH-R gene transcript in medullary histotype.

artículo científico publicado en 1994

Failure to use measurement of megalin secretory components complexed with serum thyroglobulin as a tool to identify metastases after surgery in papillary thyroid cancer

artículo científico publicado en 2004

Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study

artículo científico publicado en 2019

Fifty Years After the First Description, MEN 2B Syndrome Diagnosis Is Still Late: Descriptions of Two Recent Cases

artículo científico publicado en 2019

First report of benign track seeding after robot-assisted transaxillary thyroid surgery

artículo científico publicado en 2020

Follicular-derived neoplasms: morphometric and genetic differences.

artículo científico publicado en 2013

Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal

artículo científico publicado en 2009

FoxP3 expression in papillary thyroid carcinoma: a possible resistance biomarker to iodine 131 treatment

artículo científico publicado en 2013

Galectin-3 and Oncofetal-Fibronectin Expression in Thyroid Neoplasia as Assessed by Reverse Transcription-Polymerase Chain Reaction and Immunochemistry in Cytologic and Pathologic Specimens

artículo científico publicado en 2003

Galectin-3 is highly expressed in nonencapsulated papillary thyroid carcinoma but weakly expressed in encapsulated type; comparison with Hector Battifora mesothelial cell 1 immunoreactivity.

artículo científico publicado en 2007

Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing

scientific article published on 26 September 2019

Genetic and clinical features of multiple endocrine neoplasia types 1 and 2.

artículo científico publicado en 2012

Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas

artículo científico publicado en 1998

Genome-wide association study on differentiated thyroid cancer

scientific journal article

Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters

scientific article published on 18 October 2011

How to manage patients with differentiated thyroid cancer and a rising serum thyroglobulin level.

artículo científico publicado en 2014

Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition

artículo científico publicado en 2004

Identification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: use of a targeted differential RNA display method to select for mRNA subsets

artículo científico publicado en 1997

Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)".

artículo científico publicado en 2017

Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma

artículo científico publicado en 2020

Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.

artículo científico publicado en 2004

Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.

artículo científico

In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer.

artículo científico publicado en 2011

Incidental occurrence of metastatic medullary thyroid carcinoma in a patient with multiple endocrine neoplasia type 1 carrying germline MEN1 and somatic RET mutations

artículo científico publicado en 2017

Incidental versus clinically evident thyroid cancer: a 5-year follow-up study

artículo científico publicado en 2012

Influence of human body composition on serum peak thyrotropin (TSH) after recombinant human TSH administration in patients with differentiated thyroid carcinoma

artículo científico publicado en 2005

Inherited variants in genes somatically mutated in thyroid cancer

artículo científico publicado en 2017

Interventional bronchoscopy in the treatment of tracheal obstruction secondary to advanced thyroid cancer

artículo científico publicado en 2006

Involvement of protein kinase Cepsilon (PKCepsilon) in thyroid cell death. A truncated chimeric PKCepsilon cloned from a thyroid cancer cell line protects thyroid cells from apoptosis

artículo científico publicado en 1999

Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies

scientific article published on 04 May 2018

KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease

artículo científico publicado en 2017

Lack of evidence supporting the presence of mRNA for the thyrotropin receptor in extra-ocular muscle

artículo científico publicado en 1993

Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases.

artículo científico publicado en 2004

Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer

artículo científico publicado en 2019

Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer

artículo científico publicado en 2016

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.

artículo científico publicado en 2015

Less than 2% of the Low- and Intermediate-Risk Differentiated Thyroid Cancers Show Distant Metastases at Post-Ablation Whole-Body Scan

artículo científico publicado en 2018

Location of functioning metastases from differentiated thyroid carcinoma by simultaneous double isotope acquisition of I-131 whole body scan and bone scan

artículo científico publicado en 2004

Low prevalence of the somatic M918T RET mutation in micro-medullary thyroid cancer

artículo científico publicado en 2012

Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients.

artículo científico publicado en 2004

Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role

artículo científico publicado en 2009

Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment

artículo científico publicado en 2018

Lymphocyte and immature dendritic cell infiltrates in differentiated, poorly differentiated, and undifferentiated thyroid carcinoma

Management and follow-up of differentiated thyroid cancer not submitted to radioiodine treatment: a systematic review

artículo científico publicado en 2020

Management of Medullary Thyroid Cancer

scientific article published on 26 December 2018

Markers of cell-proliferation as prognostic factors in differentiated thyroid-cancer

scientific article published on 01 December 1993

Measurement of cAMP accumulation in Chinese hamster ovary cells transfected with the recombinant human TSH receptor (CHO-R): a new bioassay for human thyrotropin.

artículo científico publicado en 1993

Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior

article

Medullary thyroid cancer secreting carbohydrate antigen 19-9 (Ca 19-9): a fatal case report.

artículo científico publicado en 2013

Medullary thyroid cancer treated with vandetanib: predictors of a longer and durable response

artículo científico publicado en 2020

Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens

scientific article published on 01 March 1991

Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form

artículo científico

Medullary thyroid carcinoma in children.

artículo científico

Minimally invasive video-assisted thyroidectomy for papillary carcinoma: a prospective study of its completeness

artículo científico publicado en 2002

Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years

article

Molecular biology studies on mesothelioma tumor samples: preliminary data on H-ras, p21, and SV40.

artículo científico publicado en 1995

Molecular profiles of papillary thyroid tumors have been changing in the last decades: how could we explain it?

artículo científico publicado en 2014

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

artículo científico publicado en 2010

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

scholarly article by Cristina Romei et al published December 2010 in European Journal of Endocrinology

Muscle autoantigens in thyroid associated ophthalmopathy: the limits of molecular genetics

artículo científico publicado en 1993

N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression.

artículo científico publicado en 2000

Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study

artículo científico publicado en 2019

New and old knowledge on differentiated thyroid cancer epidemiology and risk factors

artículo científico publicado el 1 de enero de 2012

New breakpoints in both the H4 and RET genes create a variant of PTC-1 in a post-Chernobyl papillary thyroid carcinoma

artículo científico publicado en 2000

New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations.

artículo científico publicado en 2016

No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH

artículo científico publicado en 2020

Non thyroidal second primary malignancies in differentiated thyroid cancer patients: is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence?

scientific article published on 24 May 2020

Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk

artículo científico publicado en 2015

Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk

artículo científico publicado en 2014

Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies

artículo científico publicado en 2014

Obesity as a risk factor for thyroid cancer

artículo científico publicado en 2020

Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up

artículo científico publicado en 2020

Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients.

artículo científico publicado en 2001

Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma.

artículo científico publicado en 2017

Papillary Thyroid Carcinoma With Rare Exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience.

artículo científico publicado en 2016

Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer.

artículo científico publicado en 2017

Patients with Indeterminate Thyroid Nodules at Cytology and Cancer at Histology Have a More Favorable Outcome Compared with Patients with Suspicious or Malignant Cytology

scientific article published on 01 October 2018

Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up

artículo científico publicado en 2013

Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.

artículo científico publicado en 2009

Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma.

artículo científico publicado en 2016

Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma

artículo científico publicado en 2020

Post-surgical ablation of thyroid residues with radioiodine in Ukrainian children and adolescents affected by post-Chernobyl differentiated thyroid cancer

scientific article published on 01 June 2001

Post-surgical follow-up of differentiated thyroid cancer.

artículo científico publicado en 1995

Postoperative Thyroglobulin and Neck Ultrasound in the Risk Restratification and Decision to Perform 131I Ablation.

artículo científico publicado en 2016

Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma

artículo científico publicado en 2002

Potential Impact of BMI on the Aggressiveness of Presentation and Clinical Outcome of Differentiated Thyroid Cancer

scientific article published on 01 April 2020

Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma

artículo científico publicado en 2001

Presence of BRAF V600E in very early stages of papillary thyroid carcinoma

artículo científico publicado en 2007

Pro64His (rs4644) polymorphism within galectin-3 is a risk factor of differentiated thyroid carcinoma and affects the transcriptome of thyrocytes engineered via CRISPR/Cas9 system

scientific article published on 14 December 2020

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.

artículo científico publicado en 2008

Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study

artículo científico publicado en 2015

Protein kinase inhibitors for the treatment of advanced and progressive radiorefractory thyroid tumors: From the clinical trials to the real life

artículo científico publicado en 2017

Proteinuria is a late-onset adverse event in patients treated with cabozantinib

scientific article published on 03 May 2020

RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency

artículo científico publicado en 2020

RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population

artículo científico publicado en 2004

RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center

artículo científico publicado en 2007

RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC).

artículo científico publicado en 2011

RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases.

artículo científico publicado en 2018

RET protein expression has no prognostic impact on the long-term outcome of papillary thyroid carcinoma

artículo científico publicado en 2001

RET proto-oncogene mutations in thyroid carcinomas: clinical relevance

artículo científico publicado en 2000

RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma.

artículo científico publicado en 2012

RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults

artículo científico publicado en 2001

RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration.

artículo científico publicado en 2005

Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.

artículo científico publicado en 2005

Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma.

artículo científico publicado en 2013

Rare diseases in clinical endocrinology: a taxonomic classification system.

artículo científico publicado en 2014

Re-differentiation of thyroid carcinoma cell lines treated with 5-Aza-2'-deoxycytidine and retinoic acid.

artículo científico publicado en 2009

Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy

scientific article published on 09 July 2019

Recombinant human TSH (rhTSH) in 2009: new perspectives in diagnosis and therapy.

artículo científico publicado en 2009

Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma

artículo científico publicado en 2003

Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology

artículo científico

Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinoma

artículo científico

Reply to the Letter to the Editor by Sollini M et al

scientific article published on 03 March 2016

Response to Letter to the Editor: Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center

scientific article published on 12 May 2020

Response to Letter: "Postoperative Thyroglobulin and Neck Ultrasound in the Risk Restratification and Decision to Perform 131I Ablation"

artículo científico publicado en 2017

Retinoic acid receptor beta2 re-expression and growth inhibition in thyroid carcinoma cell lines after 5-aza-2'-deoxycytidine treatment.

artículo científico publicado en 2008

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma

artículo científico publicado en 2015

Risk of differentiated thyroid carcinoma and polymorphisms within the susceptibility cancer region 8q24.

artículo científico publicado en 2013

Role of RET codonic mutations in the surgical management of medullary thyroid carcinoma in pediatric age multiple endocrine neoplasm type 2 syndromes.

artículo científico publicado en 2010

Role of YAP-1 in Thyroid Tumor Progression and Outcome.

artículo científico publicado en 2016

Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma

artículo científico publicado en 1994

Routine serum calcitonin measurement in the evaluation of thyroid nodules.

artículo científico publicado en 2008

Runs of homozygosity and inbreeding in thyroid cancer

artículo científico publicado en 2016

Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer

scientific article published on 01 February 2019

Safety and quality of life data from an Italian expanded access program of lenvatinib for treatment of thyroid cancer

scientific article published on 10 September 2020

Simian virus 40-like sequences from early and late regions in human thyroid tumors of different histotypes

artículo científico publicado en 2003

Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence

artículo científico publicado en 1996

Somatostatin in medullary thyroid cancer. In vitro and in vivo studies.

artículo científico publicado en 1989

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

artículo científico publicado en 2014

Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation

artículo científico publicado en 1996

Studies with recombinant autoepitopes of thyroid peroxidase: evidence suggesting an epitope shared between the thyroid and the gastric parietal cell

artículo científico publicado en 1990

Successo terapeutico di Lenvatinib in seconda linea in un caso di carcinoma follicolare della tiroide avanzato

Surgical Management of Medullary Thyroid Carcinoma in Pediatric Age

artículo científico publicado en 2016

Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy

artículo científico publicado en 2009

Symptomatic and asymptomatic biliary disorders during lenvatinib treatment for advanced thyroid cancer is an underestimated problem

artículo científico publicado en 2020

T cell responses to orbital antigens in thyroid-associated ophthalmopathy

artículo científico publicado en 1994

TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations.

artículo científico publicado en 2013

Targeted Therapy in Thyroid Cancer: State of the Art.

artículo científico publicado en 2017

The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study

artículo científico publicado en 2012

The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy

scientific article published on 17 December 2019

The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer

artículo científico publicado en 2017

The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway

artículo científico publicado en 2000

The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma

artículo científico publicado en 2007

The polymorphism rs2480258 within CYP2E1 is associated with different rates of acrylamide metabolism in vivo in humans

scientific article published on 10 May 2018

The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center.

artículo científico publicado en 2011

Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels

artículo científico publicado en 1987

Thyroglobulin autoantibodies as surrogate biomarkers in the management of patients with differentiated thyroid carcinoma.

artículo científico publicado en 2014

Thyroglobulin changes are highly dependent on TSH in low-risk DTC patients not treated with 131I

scientific article published on 26 May 2020

Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper

artículo científico publicado en 2014

Thyroid autoantibodies and thyroid function in subjects exposed to Chernobyl fallout during childhood: evidence for a transient radiation-induced elevation of serum thyroid antibodies without an increase in thyroid autoimmune disease

artículo científico publicado en 2008

Thyroid autoantibodies in thyroid cancer: incidence and relationship with tumour outcome

artículo científico publicado en 1988

Thyroid cancer in children and adolescents

scientific article published on 01 December 1988

Thyroid carcinoma in thyrotoxic patients treated by surgery

artículo científico publicado en 1988

Thyroid consequences of the Chernobyl nuclear accident

artículo científico publicado en 1999

Thyroid consequences of the Chernobyl nuclear accident

Thyroid nodule and differentiated thyroid cancer management in pregnancy. An Italian Association of Clinical Endocrinologists (AME) and Italian Thyroid Association (AIT) Joint Statement for Clinical Practice

artículo científico publicado en 2010

Thyroid papillary carcinoma: preliminary evidence for a germ-line single nucleotide polymorphism in the Fas gene

article

Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancer

artículo científico publicado en 2012

Transfection with the cDNA of the human thyrotropin receptor of a poorly differentiated rat thyroid cell line (FRT).

artículo científico publicado en 1996

Treatment of advanced thyroid cancer with targeted therapies: ten years of experience

artículo científico publicado en 2016

Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acid.

artículo científico publicado en 2006

Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?

artículo científico publicado en 2014

Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations

artículo científico publicado en 2019

Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients

artículo científico publicado en 2017

Using The Cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on Cancer staging for papillary thyroid carcinoma

artículo científico publicado en 2020

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial

artículo científico publicado en 2011

Video assisted prophylactic thyroidectomy and central compartment nodes clearance in two RET gene mutation adult carriers

artículo científico publicado en 2004

Video-assisted central compartment lymphadenectomy in a patient with a positive RET oncogene: initial experience

scientific article published on 06 September 2006

mRECIST criteria to assess recurrent thyroid carcinoma treatment response after radiofrequency ablation: a prospective study.

artículo científico publicado en 2018

mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases

artículo científico publicado en 2018

somatic mutations strongly impair miRNA processing even in benign thyroid lesions

scientific article published on 05 March 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda